Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides

Virology

Volumn 220, Issue 2, 1996, Pages 274-284

  Lombardi, Stefania ^a   Massi, Claudia ^a   Indino, Esterina ^a   La Rosa, Corinna ^b   Mazzetti, Paola ^a   Falcone, Maria Laura ^a   Rovero, Paolo ^c   Fissi, Adriano ^d   Pieroni, Osvaldo ^a,d   Bandecchi, Patrizia ^a   Esposito, Fulvio ^b   Tozzini, Franco ^a   Bendinelli, Mauro ^a   Garzelli, Carlo ^a,e  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF CAMERINO   (Italy)

^c CNR   (Italy)

^d CNR Consiglio Nazionale delle Ricerche   (Italy)

^e NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SYNTHETIC PEPTIDE; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FELINE IMMUNODEFICIENCY VIRUS; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; VIRUS INHIBITION;

ANIMALIA; FELIDAE; FELINE IMMUNODEFICIENCY VIRUS;

EID: 0029952575     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0315     Document Type: Article

References (46)

1. Ackley, C. D., Hoover, E. A., and Cooper, M. D. (1990a). Identification of a CD4 homologue in the cat. Tissue Antigens 35, 92-98.
2. Ackley, C. D., Yamamoto, J. K., Levy, N., Pedersen, N. C., and Cooper, M. D. (1990b). Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus. J. Virol. 64, 5652-5655.
3. Baldinotti, F., Matteucci, D., Mazzetti, P., Giannelli, C., Bandecchi, P., Tozzini, F., and Bendinelli, M. (1994). Serum neutralization of feline immunodeficiency virus is markedly dependent on passage history of the virus and host system. J. Virol. 68, 4572-4579.
4. Bendinelli, M., Pistello, M., Lombardi, S., Poli, A., Garzelli, C., Matteucci, D., Ceccherini-Nelli, L., Malvaldi, G., and Tozzini, F. (1995). Feline immunodeficiency virus: An interesting model for AIDS studies and an important cat pathogen. Clin. Microbiol. Rev. 8, 87-112.
5. Benjouad, A., Chapuis, F., Fenouillet, E., and Gluckman, J. (1995). Multibranched peptide constructs derived from the V3 loop of envelope glycoprotein gp120 inhibit human immunodeficiency virus type 1 infection through interaction with CD4. Virology 206, 457-464.
6. Benson, D. R., Hart, B. R., Zhu, X., and Doughty, M. B. (1995). Design, synthesis and circular dichroism investigation of a peptide-sandwiched mesoheme. J. Am. Chem. Soc. 117, 8502-8510.
7. Bernstein, H. B., Tucker, S. P., Kar, S. R., McPherson, S. A., McPherson, D. T., Dubay, J. W., Lebowitz, J., Compans, R. W., and Hunter, E. (1995). Oligomerization of the hydrophobic heptad repeat of gp41. J. Virol. 69, 2745-2750.
8. + T lymphocytes. J. Virol. 65, 3359-3364.
9. Brunner, D., and Pedersen, N. C. (1989). Infection of peritoneal macrophages in vitro and in vivo with feline immunodeficiency virus. J. Virol. 63, 5483-5488.
10. Cammarota, G., Nicoletti, E., Matteucci, D., Curcio, M., Del Mauro, D., Bendinelli, M., and Pistello, M. (1996). Genotyping of 16 FIV isolates based on the gag nucleotide sequence. Third International Feline Retrovirus Research Symposium, March 6-9, 1996, Fort Collins, CO.
11. Dow, S. W., Poss, M. L., and Hoover, E. A. (1992). Feline immunodeficiency virus: A neurotropic lentivirus. J. Acquired Immune Defic. Syndr. 3, 658-668.
12. Gallaher, W. R., Ball, J. M., Garry, R. F., Griffin, M. C., and Montelaro, R. C. (1989). A general model for the transmembrane proteins of HIV and other retroviruses. AIDS Res. Hum. Retroviruses 5, 431-440.
13. Gallaher, W. R., Ball, J. M., Garry, R. F., Martin-Amedee, A. M., and Montelaro, R. C. (1995). A general model for the surface glycoproteins of HIV and other retroviruses. AIDS Res. Hum. Retroviruses 11, 191-202.
14. Golding, H., D'sousa, M. P., Bradac, J., Mathieson, J., and Fast, P. (1994). Meeting report. Neutralization of HIV-1. AIDS Res. Hum. Retroviruses 10, 633-643.
15. Henderson, L. A., and Qureshi, M. N. (1993). A peptide inhibitor of human immunodeficiency virus infection binds to a novel cell surface polypeptide. J. Biol. Chem. 268, 15291-15297.
16. Hosie, M. J., Willet, B. J., Dunsford, T. H., Jarret, O., and Neil, J. C. (1993). A monoclonal antibody which blocks infection with feline immunodeficiency virus identifies a possible non-CD4 receptor. J. Virol. 67, 1667-1671.
17. Jang, S., Lin, K., Stick, N., and Neurath, A. R. (1993a). HIV-1 inhibition by a peptide. Nature 365, 113.
18. Jang, S., Lin, K., Stick, N., and Neurath, A. R. (1993b). Inhibition of HIV-1 infection by a fusion domain binding peptide from the HIV-1 envelope glycoprotein gp41. Biochem. Biophys. Res. Commun. 195, 533-538.
19. Lombardi, S., Poli, A., Massi, C., Abramo, F., Zaccaro, L., Bazzichi, A., Malvaldi, G., Bendinelli, M., and Garzelli, C. (1994). Detection of feline immunodeficiency virus p24 antigen and p24-specific antibodies by monoclonal antibody-based assays. J. Virol. Methods 46, 287-301.
20. Lombardi, S., Garzelli, C., La Rosa, C., Zaccaro, L., Specter, S., Malvaldi, G., Tozzini, F., Esposito, F., and Bendinelli, M. (1993). Identification of a linear neutralization site within the third variable region of feline immunodeficiency virus envelope. J. Virol. 67, 4742-4749.
21. Matteucci, D., Mazzetti, P., Baldinotti, F., Zaccaro, L., and Bendinelli, M. (1995). The feline lymphoid cell line MBM and its use for feline immunodeficiency virus isolation and quantitation. Vet. Immunol. Immunopathol. 46, 71-82.
22. Moore, J. P., Cao, Y., Qing, L., Sattentau, Q. J., Pyati, J., Koduri, R., Robinson, J., Barbas, C. F., III, Burton, D. R., and Ho, D. D. (1995). Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120. J. Virol. 69, 101-109.
23. Morikawa, S., Lutz, H., Aubert, A., and Bishop, D. H. L. (1991). Identification of conserved and variable regions in the envelope glycoprotein sequences of two feline immunodeficiency viruses isolated in Zurich, Switzerland. Virus Res. 21, 53-63.
24. Neurath, A. R., Lin, K., Strick, N., and Jang, S. (1995). Two partially overlapping antiviral peptides from the external portion of HIV type 1 glycoprotein 41, adjoining the transmembrane region, affect the glycoprotein 41 fusion domain. AIDS Res. Hum. Retrovirus 11, 189-190.
25. Pancino, G., Fossati, I., Chappey, C., Castelot, S., Hurtrel, B., Moraillon, A., Klatzmann, D., and Sonigo, P. (1993). Structure and variations of feline immunodeficiency virus envelope glycoproteins. Virology 192, 659-662.
26. Pancino, G., Ellerbrok, H., Sitbon, M., and Sonigo, P. (1994). Conserved framework of envelope glycoproteins among lentiviruses. In Simian Immunodeficiency Virus, Current Topics in Microbiology and Immunology (N. L. Letvin and R. C. Desrosiers, Eds.), Vol. 188, pp. 77-105.
27. Pedersen, N. C. (1993). Feline immunodeficiency virus infection. In The Retroviridae (J. A. Levy, Ed.), Vol. 2, pp. 181-228. Plenum, New York.
28. Phillips, T. R., Talbot, R. L., Lamont, C., Muir, S., Lovelace, K., and Elder, J. H. (1990). Comparison of two host cell range variants of feline immunodeficiency virus. J. Virol. 64, 4605-4613.
29. Rigby, M. A., Holmes, E. C., Pistello, M., Mackay, A., Leigh Brown, A. J., and Neil, J. C. (1993). Evolution of structural proteins of feline immunodeficiency virus: Molecular epidemiology and evidence of selection for change. J. Gen. Virol. 74, 425-436.
30. Scholtz, J. M., Qiang, H., York, E. J., Stewart, J. M., and Baldwin, R. L. (1991). Parameters of helix-coil transition theory for alanine-based peptides of varying chain lengths in water. Biopolymers 31, 1463-1470.
31. Schulz, T. F., Jameson, B. A., Lopalco, L., Siccardi, A. G., Weiss, R. A., and Moore, J. P. (1992). Conserved structural features in the interaction between retroviral surface and transmembrane glycoprotein. AIDS Res. Hum. Retroviruses 8, 1571-1580.
32. Talbot, R. L., Sparger, E. E., Lovelace, K. M., Fitch, W. M., Pedersen, N. C., Luciw, P. A., and Elder, J. H. (1989). Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proc. Natl. Acad. Sci. USA 86, 5743-5747.
33. Tozzini, F., Matteucci, D., Bandecchi, P., Baldinotti, F., Poli, A., Pistello, M., Siebelink, K. H. J., Ceccherini-Nelli, L., and Bendinelli, M. (1992). Simple in vitro methods for titrating feline immunodeficiency virus (FIV) and FIV neutralizing antibodies. J. Virol. Methods 37, 241-252.
34. Tozzini, F., Matteucci, D., Bandecchi, P., Baldinotti, F., Poli, A., Pistello, M., Siebelink, K. H. J., Osterhaus, A., and Bendinelli, M. (1993). Neutralizing antibodies in cats infected with feline immunodeficiency virus. J. Clin. Microbiol. 31, 1626-1629.
35. Wild, C., Oas, T., McDanal, C., Bolognesi, D., and Matthews, T. (1992). A synthetic peptide inhibitor of human immunodeficiency virus replication: Correlation between solution structure and viral inhibition. Proc. Natl. Acad. Sci. USA 89, 10537-10541.
36. Wild, C., Greenwell, T. K., and Matthews, T. (1993). A synthetic peptide from HIV-1 is a potent inhibitor of virus-mediated cell-cell fusion. AIDS Res. Hum. Retroviruses 9, 1051-1053.
37. Wild, C., Shugars, D. C., Greenwell, T. K., McDanal, C. B., and Matthews, T. (1994). Peptides corresponding to a predictive α-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc. Natl. Acad. Sci. USA 91, 9770-9774.
38. Wild, C., Greenwell, T. K., Shugars, D. C., Rimsky-Clarke, L., and Matthews, T. (1995). The inhibitory activity of an HIV-1 peptide correlates with its ability to interact with a leucine zipper structure. AIDS Res. Hum. Retroviruses 11, 323-325.
39. Willet, B. J., Hosie, M. J., Jarret, O., and Neil, J. C. (1994). Identification of a putative cellular receptor for feline immunodeficiency virus as the feline homologue of CD9. Immunology 81, 228-233.
40. Willett, B. J., and Neil, J. C. (1995). cDNA cloning and eukaryotic expression of feline CD9. Mol. Immunol. 32, 417-423.
41. Yahi, N., Fantini, K. M., Tamalet, C., De Micco, P., Van Rietschoten, J., Rochat, H., and Sabatier, J. (1994). Multibranched V3 peptides inhibit human immunodeficiency virus infection in lymphocytes and macrophages. J. Virol. 68, 5714-5720.
42. Yahi, N., Fantini, J., Baghdiguian, S., Mabrouk, K., Tamalet, C., Rochat, H., Van Rietschoten, J., and Sabatier, J. (1995a). SPC3, a synthetic peptide derived from the V3 domain of human immunodeficiency virus type 1 (HIV-1) gp120, inhibits HIV-1 entry into CD4+ and CD4-cells by two distinct mechanisms. Proc. Natl. Acad. Sci. USA 92, 4867-4871.
43. Yahi, N., Sabatier, J., Baghdiguian, S., Gonzalez-Scarano, F., and Fantini, J. (1995b). Synthetic multimeric peptides derived from the principal neutralization domain (V3 loop) of human immunodeficiency virus type 1 (HIV-1) gp120 bind to galactosylceramide and block HIV-1 infection in a human CD4-negative mucosal epithelial cell line. J. Virol. 69, 320-325.
44. Yamamoto, J. K., Sparger, E., Ho, E. W., Andersen, P. R., O'Connor, T. P., Mandell, C. P., Lowenstine, L., Munn, R., and Pedersen, N. C. (1988). Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats. Am. J. Vet. Res. 49, 1246-1258.
45. Yamamoto, J. K., Acley, C. D., Zochlinski, H., Louie, H., Pembroke, E., Torten, M., Hansen, H., Munn, R., and Okuda, T. (1991). Development of IL-2-independent feline lymphoid cell lines chronically infected with feline immunodeficiency virus: Importance for diagnostic reagents and vaccines. Intervirology 32, 361-375.
46. Zanotto, C., Calderazzo, F., Dettin, M., Di Bello, C., Autiero, M., Guardiola, J., Chieco-Bianchi, L., and De Rossi, A. (1995). Minimal sequence requirements for synthetic peptides derived from the V3 loop of the human immunodeficiency virus type 1 (HIV-1) to enhance HIV-1 binding to cells and infection. Virology 206, 807-816.